Andersons pediatric cardiology 2358
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (77.82 KB, 3 trang )
Impairedexercisecapacity,inFontancirculation,1321–1324,1321f–1323f
chronotropicincompetenceand,1322
impairedsomaticgrowthand,1323–1324
preloadinsufficiencyand,1321–1322
restrictivelungdiseaseand,1322–1323
Impella,foracutecirculatoryfailure,1187
Implantablecardiacdefibrillators,forcancertherapy-relatedcardiotoxicity,1172
Implantablecardiacelectronicdevice-relatedinfectiveendocarditis,1058–1059
Implantablecardioverter/defibrillators,366–367,368f
inFontancirculation,1325–1326
forlongQTsyndrome,354
Implantablelooprecorders,forarrhythmias,358
Implantedventricularassistdevices,foruniventricularheart,1350–1351
ImprovingPediatricandAdultCongenitalTreatment(IMPACT)database,
1511t–1514t
indiagnosticcatheterization,239
INACTIVEClinicalDatabasesandRegistries,1511t–1514t
Inclusioncelldisease,cardiacinvolvementin,1092
Incrementalelasticmodulus,arterialstiffnessand,1362t
Incrementalpacing,ablationand,359
Independentvariables,410–411
Indomethacin,forhemodynamicallysignificantarterialduct,198–199
Inducibleischemia,assessmentof,986
Indwellingvascularcatheters,inFontanpathway,1274–1275,1288
InfantileMarfansyndrome,cardiacinvolvementin,1078,1101
Infants
infantrequirementfor,1496–1498
lowbirthweight
nutritionand,1500
systemicarterialdysfunctionand,1371
psychologicalstressofcardiacdiseasein,1455,1457t–1458t
supraventriculartachycardiain,345
Infection
congenitalheartdiseaseand,1526–1528,1527t
other,1528
postoperative,1528
respiratory,1527–1528,1527f
followingcardiactransplantation,1236–1237
pacemakerinsertionand,372–373
inprematurity,211
Infectiousmyocarditis,1173
Infectiveendocarditis,1043–1061
antimicrobialtherapyfor,1051–1061,1052t–1053t
antithrombotictherapyfor,1057
ofatrialseptaldefectclosuredevices,1058
bloodculture-negative,1051
empirictreatmentof,1052,1054t
brainimagingin,1046
causativeagentsof,1049,1050t–1051t,1057
inchronicrheumaticheartdisease,1032
classificationof,1043,1044t
clinicalmanifestationsof,1043–1044,1045b
computedtomographyin,1046
costofmanagement,1043
define,1043
diagnosisof,1046–1047,1047t
differentialdiagnosisof,1046–1047,1048b
echocardiographyin,1045b
epidemiologyof,1043,1044b
implantablecardiacelectronicdevice-related,1058–1059
laboratorydiagnosticproceduresfor,1049–1051
locationof,1057
long-termoutcomepostresolutionofinfection,1057
microbiologyof,1049–1061
mortalityriskof,1043
neonatal,1059
pathogenesisof,1047–1048,1048t
pediatric,incidenceof,1043
positronemissiontomography-computedtomography(PET/CT)in,1046
predisposingfactorsof,1057–1058
prophylaxisfor,1059–1061
cost-effectiveness,1061
fordentalprocedures,1059,1060b
fornondentalprocedures,1059
recommendationsof2007-2008compliance,1060
recommendationsof2007-2008(forFrance2002)Impact,1060,1060t
specificpreviousprocedureanddevice-related,1058
StaphylococcusaureusandotherStaphylococci,1049
StreptococciandEnterococcispeciesin,1049
surgicaltreatmentof,1052–1057
aorticrootabscess,1056–1057
centersof,1054
incerebralcomplications,1056
guidelineson,1052–1054
indicationsfor,1055,1055b
objectivesof,1054
outcomesof,1057
forprimaryemboliceventprevention,1055
repairversusreplacement,1054–1055
timingof,1055–1056,1056t
onsurgicallyimplantedRV-PAconduits,1058,1058t
teamfor,1061
ontranscatheterpulmonaryimplantedvalves,1058,1058t
Inference
basedonrandomsamples,412
probabilityrelatedto,412
Inferiorsinusvenousatrialseptaldefect,indiagnosticcatheterization,245–246
Inferiorvenacava,indiagnosticcatheterization,244
Inflammation,systemicarterialdysfunctionand,1374
Infliximab,forKawasakisyndrome,989
